tradingkey.logo
tradingkey.logo
Buscar

MiMedx Group Inc

MDXG
Añadir a la lista de seguimiento
3.930USD
+0.120+3.15%
Cierre 06/26, 16:00ETCotizaciones retrasadas 15 min
582.01MCap. mercado
18.91P/E TTM

Más Datos de MiMedx Group Inc Compañía

MiMedx Group, Inc. is a placental biologics company focused on providing a portfolio of products for applications in the wound care, burn, and surgical sectors of healthcare. Its product portfolio categories include Wound Care and Surgical. The Wound Care products include EPIFIX and EPIEFFECT, which are marketed for external use, such as in advanced wound care applications. Its EPICORD, EPICORD Expandable and EPIEFFECT product lines also offer an alternative treatment option to address larger, deeper wounds. Its Surgical and Other product offering includes AMNIOFIX and AMNIOEFFECT, which are used in a variety of applications and surgical settings, including lower extremity repair, plastic surgery, vascular surgery and multiple orthopedic repairs and reconstructions. It also offers HELIOGEN, an advanced bovine collagen matrix containing type I and type III collagen that is intended for the management of moderately to heavily exudating wounds and to control minor bleeding.

Información de MiMedx Group Inc

Símbolo de cotizaciónMDXG
Nombre de la empresaMiMedx Group Inc
Fecha de salida a bolsaAug 20, 2007
Director ejecutivoCapper (Joseph H)
Número de empleados837
Tipo de seguridadOrdinary Share
Fin del año fiscalAug 20
Dirección1775 W Oak Commons Court, Ne
CiudadMARIETTA
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal30062
Teléfono17706519100
Sitio Webhttps://mimedx.com/
Símbolo de cotizaciónMDXG
Fecha de salida a bolsaAug 20, 2007
Director ejecutivoCapper (Joseph H)

Ejecutivos de MiMedx Group Inc

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Joseph H. (Joe) Capper
Mr. Joseph H. (Joe) Capper
Chief Executive Officer, Director
Chief Executive Officer, Director
310.29K
-190.25%
Ms. Ricci S. Whitlow
Ms. Ricci S. Whitlow
Executive Vice President, Chief Operating Officer
Executive Vice President, Chief Operating Officer
284.25K
+28.78%
Mr. James L. Bierman
Mr. James L. Bierman
Independent Director
Independent Director
263.68K
+19.31%
Dr. Cato T. Laurencin, M.D., Ph.D.
Dr. Cato T. Laurencin, M.D., Ph.D.
Independent Director
Independent Director
181.92K
--
Ms. Dorothy E. Puhy
Ms. Dorothy E. Puhy
Independent Director
Independent Director
108.51K
+46.92%
Ms. Kimberly (Kim) Maersk-Moller
Ms. Kimberly (Kim) Maersk-Moller
Chief Commercial Officer
Chief Commercial Officer
93.15K
-28.52%
Mr. William Frank (Butch) Hulse, IV
Mr. William Frank (Butch) Hulse, IV
Chief Administrative Officer, General Counsel
Chief Administrative Officer, General Counsel
--
--
Dr. M. Kathleen Behrens Wilsey, Ph.D.
Dr. M. Kathleen Behrens Wilsey, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. K. Todd Newton
Mr. K. Todd Newton
Independent Director
Independent Director
--
--
Marty Sutter ,
Marty Sutter ,
Independent Director
Independent Director
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Joseph H. (Joe) Capper
Mr. Joseph H. (Joe) Capper
Chief Executive Officer, Director
Chief Executive Officer, Director
310.29K
-190.25%
Ms. Ricci S. Whitlow
Ms. Ricci S. Whitlow
Executive Vice President, Chief Operating Officer
Executive Vice President, Chief Operating Officer
284.25K
+28.78%
Mr. James L. Bierman
Mr. James L. Bierman
Independent Director
Independent Director
263.68K
+19.31%
Dr. Cato T. Laurencin, M.D., Ph.D.
Dr. Cato T. Laurencin, M.D., Ph.D.
Independent Director
Independent Director
181.92K
--
Ms. Dorothy E. Puhy
Ms. Dorothy E. Puhy
Independent Director
Independent Director
108.51K
+46.92%
Ms. Kimberly (Kim) Maersk-Moller
Ms. Kimberly (Kim) Maersk-Moller
Chief Commercial Officer
Chief Commercial Officer
93.15K
-28.52%

Preguntas frecuentes

¿Quiénes son los cinco principales accionistas de MiMedx Group Inc?

Los cinco principales accionistas de MiMedx Group Inc son: Mr. Joseph H. (Joe) Capper

¿Cuántas instituciones poseen acciones de MiMedx Group Inc (MDXG)?

A fecha de 2026Q1, 462 instituciones poseen acciones de MiMedx Group Inc, con un valor de mercado combinado de aproximadamente 116.77M, lo que representa el 78.40% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en 6172968.00.

¿Cuál es la mayor fuente de ganancias de MiMedx Group Inc?

El 2026Q1, el segmento empresarial Advanced Wound Care generó la ganancia más alta para MiMedx Group Inc, ascendiendo a 276.33M y representando el 66.01% de la ganancia total.
KeyAI